Angélica Nogueira - Rodrigues, MD, PhD, of the Brazilian National Cancer Insitute, and
her colleagues designed a phase 2 clinical trial to test the potential of the EFGR inhibitor erlotinib combined with chemoradiation therapy in 36 women with cervical cancer.
Not exact matches
Now, using computer simulations, James Carothers and his
colleagues at JBEI have sped up the RNA
design phase, creating computer tools that will help researchers
design molecules to precisely control gene expression in bacteria to optimize fuel production.
He and
colleagues are collaborating with the Sanford Burnham Prebys Medical Discovery Institute to
design new assays to discover the next generation of CRF receptor - 1 antagonists for testing in early
phase human safety trials.